Navigation Links
Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
Date:6/23/2008

SILVER SPRING, Md. and SOUTH SAN FRANCISCO, Calif., June 23 /PRNewswire/ -- The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc. today announced Robyn Barst as the recipient of the second annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. The grant, in the amount of $50,000, will be awarded to an institution of Dr. Barst's choice in order to support continued excellence in care for patients with PAH. The award, supported by Actelion, was presented at PHA's 8th International PH Conference being held in Houston, Texas, this weekend.

Dr. Barst was selected for her outstanding contributions to PAH patient care and clinical research, concentrated mainly on disease progression and treatment of PAH. Her studies have focused on the genetic aspects of PAH and the use of novel therapies for treatment.

"Dr. Barst has a well-established reputation of excellence in PAH clinical research and medical care," said Michael McGoon, MD, Professor of Medicine and Consultant in Cardiology at the Mayo Clinic College of Medicine and chair of the Independent Award Selection Committee. "Her passionate desire to better the lives of PAH patients through careful and concentrated research epitomizes the spirit of the PHA, and we are pleased to present this award in recognition of her devotion."

The PHA Award of Excellence in PAH Care is designed to honor and acknowledge healthcare professionals who are committed to improving outcomes for patients with PAH. It is awarded annually to outstanding care providers for clinical practice excellence in the area of PAH. The financial component of the award is directed to the recipient's choice of institution to support continued excellence in care for patients with PAH.

"The PHA Award of Excellence will encourage advances in both patient care and research in the area of PAH, a serious condition that continues to be under-recognized and under-treated," said Rino Ald
'/>"/>

SOURCE Pulmonary Hypertension Association; Actelion Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Embla Systems in Collaboration with Beth Israel Deaconess Medical Center to Develop Cardio-Pulmonary Coupling Technology
2. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
3. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
4. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
5. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
6. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
7. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
8. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
9. Presentation of Phase IIa Results for Cytos Biotechnologys Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
10. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
11. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Best Sanitizers, Inc., the ... alcohol-based hand sanitizer, asks food processors and food handling ... hand sanitizer they’re currently using to Best Sanitizers’ ... is critical to fighting cross-contamination and the spread of ... believes there are key criteria that make a hand ...
(Date:8/28/2014)... 28, 2014 The ability for organizations ... that will allow individuals to perform at the highest ... for employers looking to compete in this post–recession era. ... this trend, as the sector increasingly focuses on the ... which will have real results on the organization's development ...
(Date:8/28/2014)... by a Florida State University research team has led ... temperature, emit white light, and convert photon energy directly ... a butterfly. , Biwu Ma, associate professor in the ... College of Engineering, created the molecule in a lab ... that his creation has many other unique capabilities. , ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Supplementing ... offering a promotion for Eppendorf Safe Lock ... to purchase the highest quality tubes at an ... ideal for customers doing chemical, medical, pharmaceutical, and ... who are not regularly able to afford Eppendorf ...
Breaking Biology Technology:Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3
... 11 VIA Pharmaceuticals,(Nasdaq: VIAP ), a ... the treatment of cardiovascular disease, announced today that,Lawrence ... Stewart, senior,vice president and chief financial officer, will ... Company 28th Annual Health Care Conference on,Tuesday, March ...
... Mass., March 11 Cynosure, Inc.,(Nasdaq: CYNO ), ... of,light-based aesthetic treatment systems, today announced that President and,Chief ... Baker,will present at the following institutional investor conferences in ... Company will present at the Cowen and Company ...
... Copaxone over an Interferon-Beta Therapy, According to a New Report ... ... WALTHAM, Mass., March 11 Decision Resources, one of the,world,s ... that Teva Pharmaceutical,s Copaxone has the,greatest patient share among first- and ...
Cached Biology Technology:Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 2Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis 3
(Date:8/27/2014)... , Aug. 27, 2014  WaferGen Bio-systems, Inc. ... previously announced underwritten public offering of units of common ... unit for gross proceeds of $20 million, prior to ... by the Company.  The shares and warrants are immediately ... Each unit sold in the offering consists of 2,000 ...
(Date:8/27/2014)... West Orange, NJ. August 27, 2014. Using functional ... shown differential brain activation patterns between people with ... the first MS study in which brain activation ... cognitive task. The article, "Neuroimaging and cognition using ... was published online on June 11 by ...
(Date:8/27/2014)... fish began exploring land and evolved into tetrapods today,s ... fish used their fishy bodies and fins in a terrestrial ... mysteries. , Researchers at McGill University published in the ... Polypterus , to help show what might have happened ... Polypterus is an African fish that can breathe ...
Breaking Biology News(10 mins):WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Walking fish reveal how our ancestors evolved onto land 2
... Mental Health (CAMH) is proud to announce a landmark ... Innovation (CFI) into research that will propel the understanding, ... to the next level of excellence. This ... Research Hospital Fund will allow CAMH to leverage our ...
... new study in the September issue of the Journal ... may have a role in the rising rate of diabetes, ... , DNA is the primary mechanism of inheritance; kids get ... scientists are just starting to understand additional kinds of inheritance ...
... invasion of unwanted species, according to a recent U.S. ... the reef and eliminate all the native coral, dramatically ... This study documents for the first time that a ... reef is unambiguously associated with man-made structures. ...
Cached Biology News:Large-scale investment catapults CAMH's mental illness and addiction research forward 2Shipwrecks on coral reefs harbor unwanted species 2
... Freedom EVO Clinical is Tecans open platform ... enhance quality, safety and performance in the ... is provided by flexible barcode reading and ... mention that the system complies with the ...
... flexible on your protocols, easy on your budget. ... sample throughput instrument at a highly affordable price. ... The truly user-friendly fully interchangeable block system allows ... seconds without the need of any tools (60 ...
Preparation Note: Prepared by method of Wimmer, E., et al., Biochemistry, 7, 2623 (1968). Quality Clarifier: Acceptor Activity: approx. 1000 picomoles phenylalanine per A 260 unit (not determined b...
... system, which is based on a new flow-through ... performing in situ hybridization of tissues on microscope ... the study of gene expression, in situ hybridization ... and can be used to validate and confirm ...
Biology Products: